Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.9B |
| 2 |
Boeing
BA
|
+$956M |
| 3 |
Netflix
NFLX
|
+$804M |
| 4 |
EOG Resources
EOG
|
+$761M |
| 5 |
Wells Fargo
WFC
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$1.3B |
| 2 |
Nike
NKE
|
+$1.17B |
| 3 |
AbbVie
ABBV
|
+$1.16B |
| 4 |
McDonald's
MCD
|
+$1.15B |
| 5 |
Texas Instruments
TXN
|
+$987M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.27% |
| 2 | Technology | 16.8% |
| 3 | Communication Services | 12.6% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHR.PRA
301
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $64.7M | 0.02% |
54,900
| – | – |
|
302
McCormick & Company Non-Voting
MKC
$14.5B
| $63.9M | 0.02% |
753,452
+786
| +0.1% | +$65K |
|
303
Williams Companies
WMB
$90B
| $63M | 0.02% |
2,654,390
+360
| +0% | +$8.25K |
|
304
Granite Construction
GVA
$5.46B
| $62.7M | 0.02% |
2,265,500
+975,000
| +76% | +$27.7M |
|
305
Ryanair
RYAAY
$30.9B
| $62.3M | 0.02% |
1,776,410
+1,052,442
| +145% | +$33.7M |
|
|
FISV
306
Fiserv Inc
FISV
$28.1B
| $62.1M | 0.02% |
536,700
| – | – |
|
307
PTC
PTC
$16.1B
| $59.2M | 0.02% |
790,017
+1,136
| +0.1% | +$80.8K |
|
308
Pfizer
PFE
$153B
| $58.9M | 0.02% |
1,584,119
+1,652
| +0.1% | +$58.8K |
|
309
Cognex
CGNX
$10.3B
| $58.8M | 0.02% |
1,050,000
| – | – |
|
310
M&T Bank
MTB
$36.7B
| $56.6M | 0.02% |
333,600
| – | – |
|
311
Molina Healthcare
MOH
$10.8B
| $54.5M | 0.02% |
401,585
+1,265
| +0.3% | +$159K |
|
312
Silicon Laboratories
SLAB
$7.31B
| $53.7M | 0.02% |
463,000
| – | – |
|
313
Cedar Fair
FUN
$1.74B
| $53.3M | 0.02% |
961,800
-544,200
| -36% | -$30.6M |
|
|
EIGI
314
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $53.1M | 0.02% |
11,304,955
| – | – |
|
|
OCFT
315
DELISTED
OneConnect Financial Technology
OCFT
| $52.2M | 0.02% |
+520,000
| New | +$51.6M |
|
316
Emerson Electric
EMR
$89.5B
| $52.1M | 0.02% |
683,147
+682
| +0.1% | +$49.1K |
|
317
MakeMyTrip
MMYT
$5.63B
| $51.9M | 0.02% |
2,268,356
-1,081
| -0% | -$26.1K |
|
318
Cisco
CSCO
$448B
| $51.2M | 0.02% |
1,067,613
-841,112
| -44% | -$39.1M |
|
319
Prologis
PLD
$135B
| $51M | 0.02% |
+572,106
| New | +$50.7M |
|
|
JHG
320
DELISTED
Janus Henderson
JHG
| $49.5M | 0.01% |
2,025,000
| – | – |
|
321
Ferrari
RACE
$72.2B
| $48.9M | 0.01% |
295,000
| – | – |
|
|
PRMW
322
DELISTED
Primo Water Corporation
PRMW
| $47.8M | 0.01% |
4,258,557
+98,000
| +2% | +$1.09M |
|
323
State Street
STT
$52B
| $47.6M | 0.01% |
601,192
+622
| +0.1% | +$43.8K |
|
|
GOOS
324
Canada Goose Holdings
GOOS
$846M
| $46.7M | 0.01% |
1,289,870
+216
| +0% | +$8.34K |
|
325
Lumen
LUMN
$6.46B
| $46.4M | 0.01% |
3,511,898
+1,338
| +0% | +$17.9K |
|
Similar funds
Capital Research Global Investors's Q4 2019 Portfolio in Review
As of Q4 2019, Capital Research Global Investors held 433 positions worth $333B, up 9.4% from $305B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q4 2019 filing shows 19 new, 239 increased, 105 reduced and 28 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M. The largest sale was Fidelity National Information Services, an estimated $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M.
- Capital Research Global Investors added most to UnitedHealth in Q4 2019, an estimated $1.9B increase.
- Capital Research Global Investors's biggest Q4 2019 reduction was Fidelity National Information Services, cutting an estimated $1.3B.
- Capital Research Global Investors fully exited 3M in Q4 2019, selling an estimated $654M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $333B portfolio in Q4 2019.
- Capital Research Global Investors opened 19 new positions and closed 28 in Q4 2019.
- Capital Research Global Investors's portfolio value rose 9.4% quarter-over-quarter to $333B.
Based on Capital Research Global Investors's 13F filing for Q4 2019, filed 18 Feb 2020.